How many Bellerophon Therapeutics shares are in issue?
Bellerophon Therapeutics has 9,646,000 shares in issue.
What is the market cap of Bellerophon Therapeutics?
The market capitalisation of Bellerophon Therapeutics is USD 23.54 M.
What is the 1 year trading range for Bellerophon Therapeutics share price?
Bellerophon Therapeutics has traded in the range of US$ 2.44 to US$ 2.44 during the past year.
What is the PE ratio of Bellerophon Therapeutics?
The price to earnings ratio of Bellerophon Therapeutics is -0.05.
What is the reporting currency for Bellerophon Therapeutics?
Bellerophon Therapeutics reports financial results in USD.
What is the latest annual profit for Bellerophon Therapeutics?
The latest annual profit of Bellerophon Therapeutics is USD -19.83M.
What is the registered address of Bellerophon Therapeutics?
The registered address for Bellerophon Therapeutics is 251 LITTLE FALLS DRIVE, NEW CASTLE, WILMINGTON, DELAWARE, 19808.
Which industry sector does Bellerophon Therapeutics operate in?
Bellerophon Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Hot Features
Premium
